VKTX
Viking Therapeutics Inc
NASDAQ: VKTX · HEALTHCARE · BIOTECHNOLOGY
$30.00
-3.78% today
Updated 2026-05-01
Market cap
$3.63B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.19
Dividend yield
—
52W range
$23 – $43
Volume
2.4M
Viking Therapeutics Inc (VKTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-47.30%
ROA
-30.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-444.00 | — | — | — |
| 2013 | — | $-146247.00 | — | — | — |
| 2014 | $0.00 | $-21.88M | — | — | — |
| 2015 | $0.00 | $-23.40M | — | — | — |
| 2016 | $0.00 | $-14.73M | — | — | — |
| 2017 | $0.00 | $-20.58M | — | — | — |
| 2018 | $0.00 | $-22.06M | — | — | — |
| 2019 | $0.00 | $-25.78M | — | — | — |
| 2020 | $10731.00 | $-39.49M | 100.00% | -397,558.48% | -368,045.85% |
| 2021 | $10701.00 | $-54.99M | -2,766.10% | -520,343.89% | -513,877.21% |
| 2022 | $0.00 | $-68.87M | — | — | — |
| 2023 | $0.00 | $-85.89M | — | — | — |
| 2024 | $0.00 | $-109.96M | — | — | — |
| 2025 | $0.00 | $-359.64M | — | — | — |